Drugs and Devices

FDA approves Brintellix for major depression

On Sept. 30, the U.S. Food and Drug Administration (FDA) approved Brintellix (vortioxetine) to treat adults with major depressive disorder. Read more.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares